
AstraZeneca has ended the month with more positive news on Tagrisso, that had previously been approved in China under its …

AstraZeneca announced that it has sold Zoladex’s (goserelin acetate implant) commercial rights in the US and Canada to TerSera Therapeutics. …

AstraZeneca says it plans to invest around £120 million in a new cancer drug manufacturing facility at its plant in …

AstraZeneca has launched a new app that helps prostate cancer patients to monitor their PSA levels. It is not the …

